COVID-19 Vaccine Cross-Border Liability and Compensation
The first doses of newly approved vaccines for coronavirus disease 2019 (COVID-19) are slowly rolling out to the public. A RAND virtual event focused on (1) facilitating global distribution of COVID-19 vaccines and (2) preventing liability and compensation concerns from affecting the vaccine supply chain and public uptake of the vaccine.